AngioDynamics Inc (FRA:UG2)
€ 6.15 -0.1 (-1.67%) Market Cap: 251.87 Mil Enterprise Value: 205.71 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 66/100

AngioDynamics Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 01:00PM GMT
Release Date Price: €18.2 (+2.82%)
Travis Steed

Good morning, everybody. This is Travis Steed. I'm the medtech analyst at Barclays. And up next, we have AngioDynamics, Jim Clemmer, President and CEO; and Stephen Trowbridge, Vice President and Chief Financial Officer. We'll hand the floor to them. They're going to give a presentation this morning. So Jim, well, you can start whenever you're ready.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

(technical difficulty)

Operator

Jim, I'm so sorry for interrupting you, but we can't hear you.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

We'll apologize for an audio -- technical difficulty this morning. We'll realign the slides. And folks, sorry for the technical difficulty. We'll go back to the very beginning. That we remind investors, thank you for joining us. The forward-looking statements that are important to remind people what you'll hear from us in the next few minutes, our strategies and ideas we have to improve our company,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot